Inhibitor Report for: Evogliptin
Evogliptin | Type | Drug |
| | Gliptin |
| | Trifluoro |
| Other_Name (5) |
| Chemical_Nomenclature | (3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-[(2-methylpropan-2-yl)oxymethyl]piperazin-2-one |
| Formula | C19H26F3N3O3 |
| CAS_number | 1222102-29-5 |
| MW | 401.43 |
| |
| Paper (19) |
| Structure | 5Y7K |
| Comment | Derivative of DA-1266. DDP4 IC50 0.666 nM |
| Gene_locus | human-DPP4 |
| CID | 25022354 |
| Family | DPP4N_Peptidase_S9 |
| InChIKey | LCDDAGSJHKEABN-MLGOLLRUSA-N |
| CanonicalSMILES | CC(C)(C)OCC1C(=O)NCCN1C(=O)CC(CC2=CC(=C(C=C2F)F)F)N |
| InChI | InChI=1S/C19H26F3N3O3/c1-19(2,3)28-10-16-18(27)24-4-5-25(16)17(26)8-12(23)6-11-7-14(21)15(22)9-13(11)20/h7,9,12,16H,4-6,8,10,23H2,1-3H3,(H,24,27)/t12-,16-/m1/s1 |
| Wikipedia | Evogliptin |
|
|